PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Clinical trials for PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug VBC103 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called VBC103 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 255 participants will take part in this early-p…
Matched conditions: PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated May 03, 2026 20:22 UTC
-
New drug VBC101 targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called VBC101 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to attach to two cancer-related targets (EGFR and cMET) to deliver a toxic payload directly to cancer cells. The trial has two parts…
Matched conditions: PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated May 01, 2026 15:58 UTC